F
4D Molecular Therapeutics D
D
FDMT
4.13500
USD
0.07
(1.60%)
مغلق
حجم التداول
0
الربح لكل سهم
-4
العائد الربحي
-
P/E
-1
حجم السوق
191,552,395
العنوان: 4D Molecular Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.